Komipharm International's chart data is dated 2026-10-08. Recorded technical signals: 52-week high, MA aligned, Bollinger breakout, MACD bullish cross. There are 5 published signal records.
Komipharm International last closed at ₩11,480 (+4.36%) on 2026-10-08. Signals today: 52-week high, MA aligned, Bollinger breakout, MACD bullish cross. Listed on KOSDAQ. Trailing 12 months PER is -316.2×. Its overall grade ranks 121 of 308 stocks in Healthcare.
About this company
Komipharm International last closed at ₩11,480 (+4.36%) on 2026-10-08. Signals today: 52-week high, MA aligned, Bollinger breakout, MACD bullish cross. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 121/308
Valuation grade F
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 삼성바이오로직스Competitor
바이오의약품 위탁개발·생산(CDMO) 및 바이오 신약 분야에서 국내 대표 경쟁사
- 셀트리온Competitor
바이오의약품·항암제·항체치료제 개발 분야의 국내 대형 경쟁사
- 유한양행Competitor
신약 개발 및 항암제 파이프라인에서 국내 제약 경쟁사
About Komipharm International
- What technical signals does Komipharm International (041960) have?
- Komipharm International current technical signals: MA alignment (score 0.76).
- Is Komipharm International a cup-and-handle pattern?
- No. Komipharm International has no valid Cup signal right now.
- What published figures are available for Komipharm International?
- Market cap: KRW 846.75B. Trailing 12 months PER: -316.2×. Latest quarter PBR: 11.39×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Komipharm International, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.